However, dedicated studies investigating currently recommended GLP-1Ra (semaglutide, dulaglutide, and liraglutide) in ACS patients are still lacking, and the only trial exclusively enrolling patients with recent ACS - the ELIXA trial - failed to demonstrate the superiority of lixisenatide over placebo [42]
Glutathione Glutathione supplementation is generally well-tolerated due to its endogenous nature, but some individuals may experience side effects, particularly with higher doses or sensitive constitutions
K., Rastogi, A., Bansal, A., Donnelly, J
Ryan GJ, Jobe LJ, Martin R (October 2005)
However, many expected and unexpected side effects are associated with using Ozempic